- Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Fosaprepitant dimeglumine; Drug: Fosaprepitant Placebo; Drug: Dexamethasone 12 mg; Drug: Dexamethasone 20 mg; Drug: Ondansetron; Drug: Rescue Therapy; Drug: Ondansetron; Drug: Dexamethasone Placebo; Drug: Ondansetron Placebo
Sponsors: Merck; Merck
Not yet recruiting - verified May 2012 - Condition: Nausea and Vomiting
Interventions: Drug: lorazepam; Drug: diphenhydramine hydrochloride; Drug: haloperidol; Other: placebo
Sponsors: Virginia Commonwealth University; Virginia Commonwealth University; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Conditions: Delirium; Advanced Cancer
Interventions: Drug: Olanzapine; Drug: Haloperidol
Sponsors: VU University Medical Center; VU University Medical Center; ZonMw: The Netherlands Organisation for Health Research and Development
Recruiting - verified February 2012 - Condition: Agitation
Interventions: Drug: Haloperidol; Drug: Midazolam
Sponsors: Catholic Health East; Catholic Health East
Recruiting - verified December 2011 - Condition: Delirium
Interventions: Drug: Haloperidol; Drug: Placebo
Sponsors: VU University Medical Center; VU University Medical Center
Not yet recruiting - verified February 2012 - Conditions: Delirium; Impaired Cognition; Long Term Psychologic Disorders
Interventions: Drug: Haloperidol; Drug: Ziprasidone; Drug: Placebo
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified December 2011 - Condition: Subsyndromal Delirium
Interventions: Drug: Haloperidol decanoate; Drug: Placebo
Sponsors: Northeastern University; Northeastern University; National Institute on Aging (NIA)
Recruiting - verified April 2012 - Condition: Schizophrenia
Interventions: Drug: Olanzapine; Drug: Flupentixol; Drug: Quetiapine; Drug: Aripiprazole; Drug: Haloperidol
Sponsors: University of Bremen; University of Bremen; German Federal Ministry of Education and Research
Recruiting - verified April 2012 - Conditions: Schizophrenia; Schizoaffective Disorder
Interventions: Drug: haloperidol decanoate; Drug: paliperidone palmitate
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute of Mental Health (NIMH); Duke University; University of North Carolina, Chapel Hill
Recruiting - verified January 2012 - Condition: Schizophrenia
Interventions: Drug: paliperidone; Drug: risperidone; Drug: haloperidole; Drug: perphenazine; Drug: aripiprazole; Drug: quetiapine; Drug: paliperidone palmitate; Drug: olanzapine
Sponsors: Janssen Scientific Affairs, LLC; Janssen Scientific Affairs, LLC
Recruiting - verified May 2012
 |
Join Clinical Trials for Haloperidol |
